Tobacco Control

Share

Tobacco products are projected to kill one billion people worldwide this century. And the industry is showing no signs of slowing down, spending more than $9 billion on marketing each year. 

Despite the industry's deceptive and deadly practices, ACS CAN continues to have enormous success passing local, state and federal laws that prevent children from smoking, help adults quit and ensure the government uses its authority to regulate tobacco industry practices.

While our work has had an enormous impact on youth cigarette use - now at historic lows - the use of e-cigarettes among kids is skyrocketing.  This further reinforces the importance of continuing this lifesaving work.

Latest Updates

January 18, 2022
New York

Governor Hochul has released her Executive Budget for the next fiscal year. ACS CAN is asking for increases in funding for the Cancer Services Program and tobacco control.

January 13, 2022

Today the Senate Health, Education, Labor and Pension (HELP) Committee voted to confirm Robert Califf as the next commissioner of the Food and Drug Administration (FDA).

January 5, 2022
Massachusetts

A newly released, first of its kind study by the American Cancer Society (ACS) shows that Massachusetts’ law ending the sale of all flavored tobacco products, including menthol flavored cigarettes, implemented in June 2020, tremendously decreased menthol and all (menthol and nonflavored) cigarette sales in the state.

December 13, 2021
Colorado

Today, the Denver City Council voted 8-4 against overriding Denver Mayor Michael Hancock’s veto of a bill aimed at significantly curbing the sale of flavored tobacco products. The American Cancer Society Cancer Action Network (ACS CAN) is disappointed in the decision to prioritize Big Tobacco’s interests and bottom line over

Tobacco Control Resources

In order to effectively reduce tobacco use, it is important to understand the impact of the retail availability of tobacco products. The presence of tobacco retailers can undermine a community’s ability to establish tobacco-free social norms by increasing accessibility to tobacco products including e-cigarettes and increasing exposure to tobacco industry point of sale advertising, marketing and promotions. 

Because JUUL’s products continue to have the largest share of the e-cigarette market, and therefore presumably are undergoing expedited review, we write at this time to express our conclusion that based on all of the publicly available evidence, no JUUL product currently on the market can meet the statutory public health standard. Therefore, they should not receive a marketing order.